Sensitivity of SARS-CoV-2 Variants to Neutralization by Convalescent Sera and a VH3-30 Monoclonal Antibody

The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has caused a global pandemic of novel coronavirus disease (COVID-19). Though vaccines and neutralizing monoclonal antibodies (mAbs) have been developed to fight COVID-19 in the past year, one major concern is the emergence of SARS-CoV-...

Descripción completa

Detalles Bibliográficos
Autores principales: Yue, Shuai, Li, Zhirong, Lin, Yao, Yang, Yang, Yuan, Mengqi, Pan, Zhiwei, Hu, Li, Gao, Leiqiong, Zhou, Jing, Tang, Jianfang, Wang, Yifei, Tian, Qin, Hao, Yaxing, Wang, Juan, Huang, Qizhao, Xu, Lifan, Zhu, Bo, Liu, Pinghuang, Deng, Kai, Wang, Li, Ye, Lilin, Chen, Xiangyu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8495157/
https://www.ncbi.nlm.nih.gov/pubmed/34630430
http://dx.doi.org/10.3389/fimmu.2021.751584

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8495157/
https://www.ncbi.nlm.nih.gov/pubmed/34630430
http://dx.doi.org/10.3389/fimmu.2021.751584

Ejemplares similares